18
Participants
Start Date
August 31, 2013
Primary Completion Date
February 8, 2017
Study Completion Date
February 8, 2017
Low Dose - AbobotulinumtoxinA
"Participants will receive low dose AbobotulinumtoxinA injections. Location of injections will be determined by the clinician to treat the individual's dystonic symptom.~Muscles that may be included for in injection for OMD with Jaw Closing:~Medial Pterygoid 50 units, Masseter 25 units~Muscles that may be included in injection for OMD with Jaw Opening:~Lateral Pterygoid 50 units, Anterior digastrics 10 units~Muscle that will be included in injection for OMD with Tongue Protrusion:~Genioglossus 7.5 units"
Wesley Woods Health Center; Emory University Hospital, Atlanta
Collaborators (1)
Ipsen
INDUSTRY
Emory University
OTHER